Back to library

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Growth Hormone Axis · Small Molecule

MK-677 (Ibutamoren) Peptide

Orally bioavailable non-peptide ghrelin mimetic.

Wellness category: Performance
Medically reviewed for educational accuracy
Published Last reviewed

What is MK-677 (Ibutamoren)?

MK-677 (Ibutamoren) is a growth hormone axis · small molecule peptide studied for gh/igf-1 elevation in adults and lean mass and bone density in elderly. Below is an educational overview of MK-677 (Ibutamoren) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.

MK-677 (Ibutamoren) Mechanism of Action

Technically a small-molecule ghrelin receptor agonist (not a peptide), often grouped with peptide GH research. Orally bioavailable, it elevates GH and IGF-1 over 24 hours and increases appetite.

MK-677 (Ibutamoren) Research Areas & Benefits

GH/IGF-1 elevation in adults
Lean mass and bone density in elderly
Sleep quality (slow-wave sleep)

MK-677 (Ibutamoren) Dosage & Common Research Protocols

Daily oral research dosing

Once-daily oral administration in long-running clinical pharmacology trials.

Protocols summarized for educational reference from published research. Not dosing guidance.

MK-677 (Ibutamoren) Studies & Cited Research

[1]Annals of Internal Medicine·2008 Peer-reviewed

MK-677 increases GH and IGF-1 in elderly adults

Two-year RCT showing sustained IGF-1 elevation and lean mass increase.

Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.

Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).

MK-677 (Ibutamoren) Side Effects & Safety Considerations

  • Not FDA-approved.
  • Insulin resistance and fluid retention reported.
  • Banned by WADA.

Common questions about MK-677 (Ibutamoren)

More Performance peptides · See all 14

Educational Information Only — Not Medical Advice

All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.

Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.

Searching the library…

Ask the Library

Ask anything about peptides — answers come from our curated reference library with citations.

Find a pharmacy that carries MK-677 (Ibutamoren)

Leave your details and a vetted partner pharmacy will reach out with availability and pricing.